Hannu Mönkkönen

2.8k total citations
29 papers, 2.3k citations indexed

About

Hannu Mönkkönen is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hannu Mönkkönen has authored 29 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hannu Mönkkönen's work include Bone health and treatments (24 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Bone and Joint Diseases (7 papers). Hannu Mönkkönen is often cited by papers focused on Bone health and treatments (24 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Bone and Joint Diseases (7 papers). Hannu Mönkkönen collaborates with scholars based in Finland, France and United Kingdom. Hannu Mönkkönen's co-authors include Jukka Mönkkönen, Seppo Auriola, Philippe Clézardin, Ingunn Holen, Michael J. Rogers, Ismahène Benzaïd, Marjo Jauhiainen, Verena Stresing, Penelope D. Ottewell and Keith Thompson and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Hannu Mönkkönen

28 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hannu Mönkkönen Finland	21	1.5k	876	594	548	357	29	2.3k
Verena Stresing France	12	432 0.3×	123 0.1×	390 0.7×	144 0.3×	94 0.3×	14	919
Luigia Stefania Stucci Italy	21	759 0.5×	482 0.6×	642 1.1×	59 0.1×	33 0.1×	46	1.5k
V Castronovo Belgium	27	674 0.5×	658 0.8×	1.4k 2.3×	179 0.3×	18 0.1×	38	2.3k
Sungyoul Hong United States	19	605 0.4×	684 0.8×	634 1.1×	67 0.1×	29 0.1×	35	1.5k
DA Scheinberg United States	18	476 0.3×	452 0.5×	1.1k 1.8×	460 0.8×	37 0.1×	34	2.0k
Marianne Budde Netherlands	12	359 0.2×	156 0.2×	553 0.9×	716 1.3×	25 0.1×	14	1.4k
Venkatesh Krishnan United States	20	758 0.5×	961 1.1×	1.1k 1.8×	99 0.2×	15 0.0×	35	2.3k
Bindu Varghese United States	15	675 0.5×	1.4k 1.6×	419 0.7×	249 0.5×	12 0.0×	25	2.1k
Maya Kansara Australia	14	574 0.4×	229 0.3×	1.3k 2.2×	67 0.1×	41 0.1×	31	2.2k
Kevin W. Harris United States	21	383 0.3×	592 0.7×	400 0.7×	67 0.1×	21 0.1×	34	1.2k

Countries citing papers authored by Hannu Mönkkönen

Since Specialization

Citations

This map shows the geographic impact of Hannu Mönkkönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannu Mönkkönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannu Mönkkönen more than expected).

Fields of papers citing papers by Hannu Mönkkönen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannu Mönkkönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannu Mönkkönen. The network helps show where Hannu Mönkkönen may publish in the future.

Co-authorship network of co-authors of Hannu Mönkkönen

This figure shows the co-authorship network connecting the top 25 collaborators of Hannu Mönkkönen. A scholar is included among the top collaborators of Hannu Mönkkönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannu Mönkkönen. Hannu Mönkkönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mönkkönen, Hannu, Johanna Räikkönen, Ismahène Benzaïd, et al.. (2014). Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vγ9Vδ2 T cell cytotoxicity in PC-3 prostate cancer cells. Cancer Letters. 357(1). 279–285. 9 indexed citations

Harly, Christelle, Yves Claude Guillaume, Steven Nédellec, et al.. (2012). Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. Blood. 120(11). 2269–2279. 417 indexed citations

Benzaïd, Ismahène, Hannu Mönkkönen, Edith Bonnelye, Jukka Mönkkönen, & Philippe Clézardin. (2012). In Vivo Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Trigger Vγ9Vδ2 T-cell Antitumor Cytotoxicity through ICAM-1 Engagement. Clinical Cancer Research. 18(22). 6249–6259. 43 indexed citations

Benzaïd, Ismahène, Hannu Mönkkönen, Verena Stresing, et al.. (2011). High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote Vγ9Vδ2 T-Cell Chemotaxis and Cytotoxicity In Vivo. Cancer Research. 71(13). 4562–4572. 124 indexed citations

Räikkönen, Johanna, et al.. (2011). Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells. Biochemical and Biophysical Research Communications. 407(4). 663–667. 14 indexed citations

Mitrofan, Laura, Seppo Auriola, Hannu Mönkkönen, & Jukka Mönkkönen. (2010). Assessment of Bishosphonate Activity In Vitro. Current Pharmaceutical Design. 16(27). 2970–2980. 1 indexed citations

Stresing, Verena, Pierrick G.J. Fournier, Akeila Bellahcène, et al.. (2010). Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase. Bone. 48(2). 259–266. 76 indexed citations

Cabillic, Florian, Olivier Toutirais, Vincent Lavoué, et al.. (2010). Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients. Cancer Immunology Immunotherapy. 59(11). 1611–1619. 59 indexed citations

Coscia, Marta, Elena Quaglino, Manuela Iezzi, et al.. (2009). Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. Journal of Cellular and Molecular Medicine. 14(12). 2803–2815. 220 indexed citations

10.

Räikkönen, Johanna, Hannu Mönkkönen, Seppo Auriola, & Jukka Mönkkönen. (2009). Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells. Biochemical Pharmacology. 79(5). 777–783. 40 indexed citations

11.

Thompson, Keith, Anke J. Roelofs, Marjo Jauhiainen, et al.. (2009). Activation of γδ T Cells by Bisphosphonates. Advances in experimental medicine and biology. 658. 11–20. 64 indexed citations

12.

Mönkkönen, Hannu, Ingunn Holen, Diane V. Lefley, et al.. (2008). Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth. Anti-Cancer Drugs. 19(4). 391–399. 63 indexed citations

13.

Roelofs, Anke J., Marjo Jauhiainen, Hannu Mönkkönen, et al.. (2008). Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP. British Journal of Haematology. 144(2). 245–250. 232 indexed citations

14.

Mönkkönen, Hannu, et al.. (2007). Zoledronic acid-induced IPP/ApppI production in vivo. Life Sciences. 81(13). 1066–1070. 53 indexed citations

15.

Stresing, Verena, Florence Daubiné, Ismahène Benzaïd, Hannu Mönkkönen, & Philippe Clézardin. (2007). Bisphosphonates in cancer therapy. Cancer Letters. 257(1). 16–35. 158 indexed citations

16.

Mönkkönen, Hannu, et al.. (2006). Zoledronic acid induced IPP/ApppI accumulation in different cancer cell lines. Bone. 38(3). 58–58. 1 indexed citations

17.

Mönkkönen, Hannu, Seppo Auriola, Petri Lehenkari, et al.. (2006). A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen‐containing bisphosphonates. British Journal of Pharmacology. 147(4). 437–445. 232 indexed citations

18.

Mönkkönen, Hannu, Jukka Mönkkönen, Hannu‐Ville Leskelä, et al.. (2005). In vitro Comparison of Clodronate, Pamidronate and Zoledronic Acid Effects on Rat Osteoclasts and Human Stem Cell‐Derived Osteoblasts. Basic & Clinical Pharmacology & Toxicology. 97(6). 382–391. 61 indexed citations

19.

Mönkkönen, Hannu, Soili Törmälehto, Riku Niemi, et al.. (2003). Cellular uptake and metabolism of clodronate and its derivatives in Caco-2 cells: a possible correlation with bisphosphonate-induced gastrointestinal side-effects. European Journal of Pharmaceutical Sciences. 19(1). 23–29. 16 indexed citations

20.

Mönkkönen, Hannu, et al.. (2000). Analysis of an adenine nucleotide-containing metabolite of clodronate using ion pair high-performance liquid chromatography–electrospray ionisation mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 738(2). 395–403. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact